Literature DB >> 21317649

Efficacy of portable and percutaneous cardiopulmonary bypass rewarming versus that of conventional internal rewarming for patients with accidental deep hypothermia.

Seiji Morita1, Sadaki Inokuchi, Takeshi Yamagiwa, Shinichi Iizuka, Rie Yamamoto, Hiromichi Aoki, Mayumi Okada.   

Abstract

OBJECTIVE: Since 2001, at our institution, a portable and percutaneous cardiopulmonary bypass system has been used for rewarming of patients with accidental deep hypothermia. Before 2001, a conventional internal rewarming technique was used. The aim of this research is to examine the efficacy of portable and percutaneous cardiopulmonary bypass for rewarming of patients with accidental severe hypothermia and compare it with that of conventional rewarming methods.
DESIGN: Historical study.
SETTING: The exclusive emergency medical center and trauma center level 1 in Western Kanagawa, Japan. PATIENTS: From April 1992 to March 2009, 70 patients with accidental deep hypothermia (core temperature <28°C) were transferred to our hospital. Two patients presented with intracranial hemorrhage on initial head computed tomography scans. These two patients were excluded because each required an emergency operation. Therefore, 68 patients were included in this study. We compared patients' clinical characteristics and outcomes. The parameters included the following: sex, age, vital signs on arrival to our hospital (Glasgow coma Scale scores, systolic blood pressure, heart rate, respiratory rate, core temperature), electrocardiogram on arrival to our hospital, rewarming speed, time of rewarming until 34°C was reached, ventricular fibrillation occurrence rate during rewarming, cause of cold environmental exposure, Glasgow Outcome Scale scores, and mortality. In addition, we divided the conventional and portable and percutaneous cardiopulmonary bypass rewarming groups into two categories depending on whether cardiopulmonary arrest occurred on arrival to our hospital. We also compared the survival rate and average Glasgow Outcome Scale scores for each group.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Patients' clinical backgrounds did not differ significantly between the conventional and portable and percutaneous cardiopulmonary bypass rewarming groups. Glasgow Outcome Scale scores and survival rates of the portable and percutaneous cardiopulmonary bypass rewarming group patients, irrespective of whether cardiopulmonary arrest was experienced on arrival to our hospital, were significantly higher than those of the conventional rewarming group.
CONCLUSIONS: Portable and percutaneous cardiopulmonary bypass rewarming can improve the mortality rates and Glasgow Outcome Scale scores of accidental deep hypothermia patients.

Entities:  

Mesh:

Year:  2011        PMID: 21317649     DOI: 10.1097/CCM.0b013e31820edd04

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  20 in total

1.  Use of extracorporeal life support for active rewarming in a hypothermic, nonarrested patient with multiple trauma.

Authors:  Daniel K Ting; Douglas J A Brown
Journal:  CMAJ       Date:  2018-06-11       Impact factor: 8.262

2.  Severe accidental hypothermia treated with cardiopulmonary bypass.

Authors:  Mohammed Akil Dilawar Gani; Balraj Singh Jagdev; Asgher Champsi; Uday Dandekar
Journal:  BMJ Case Rep       Date:  2016-09-29

3.  Extracorporeal membrane oxygenation for accidental deep hypothermia-current challenges and future perspectives.

Authors:  Piotr Mazur; Sylweriusz Kosiński; Paweł Podsiadło; Anna Jarosz; Roman Przybylski; Radosław Litiwnowicz; Jacek Piątek; Janusz Konstanty-Kalandyk; Robert Gałązkowski; Tomasz Darocha
Journal:  Ann Cardiothorac Surg       Date:  2019-01

Review 4.  When should cardiopulmonary bypass be used in the setting of severe hypothermic cardiac arrest?

Authors:  Amir H Sepehripour; Shradha Gupta; Kulvinder S Lall
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-05-23

5.  Rewarming From Hypothermic Cardiac Arrest Applying Extracorporeal Life Support: A Systematic Review and Meta-Analysis.

Authors:  Lars J Bjertnæs; Kristian Hindberg; Torvind O Næsheim; Evgeny V Suborov; Eirik Reierth; Mikhail Y Kirov; Konstantin M Lebedinskii; Torkjel Tveita
Journal:  Front Med (Lausanne)       Date:  2021-05-13

Review 6.  Accidental hypothermia-an update : The content of this review is endorsed by the International Commission for Mountain Emergency Medicine (ICAR MEDCOM).

Authors:  Peter Paal; Les Gordon; Giacomo Strapazzon; Monika Brodmann Maeder; Gabriel Putzer; Beat Walpoth; Michael Wanscher; Doug Brown; Michael Holzer; Gregor Broessner; Hermann Brugger
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2016-09-15       Impact factor: 2.953

7.  Clinical course and prognostic factors of patients in severe accidental hypothermia with circulatory instability rewarmed with veno-arterial ECMO - an observational case series study.

Authors:  Sylweriusz Kosiński; Tomasz Darocha; Anna Jarosz; Aleksander Zeliaś; Mirosław Ziętkiewicz; Paweł Podsiadło; Tomasz Sanak; Kinga Sałapa; Jacek Piątek; Janusz Konstany-Kalandyk; Robert Gałązkowski; Paweł Krawczyk; Łukasz Krzych; Rafał Drwiła
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2017-05-02       Impact factor: 2.953

8.  In-hospital mortality and successful weaning from venoarterial extracorporeal membrane oxygenation: analysis of 5,263 patients using a national inpatient database in Japan.

Authors:  Shotaro Aso; Hiroki Matsui; Kiyohide Fushimi; Hideo Yasunaga
Journal:  Crit Care       Date:  2016-04-05       Impact factor: 9.097

9.  Severe Hypothermia Management in Mountain Rescue: A Survey Study.

Authors:  Paweł Podsiadło; Tomasz Darocha; Sylweriusz Kosiński; Kinga Sałapa; Mirosław Ziętkiewicz; Tomasz Sanak; Rachel Turner; Hermann Brugger
Journal:  High Alt Med Biol       Date:  2017-10-02       Impact factor: 1.981

Review 10.  Pre-hospital extra-corporeal cardiopulmonary resuscitation.

Authors:  Ben Singer; Joshua C Reynolds; David J Lockey; Ben O'Brien
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2018-03-27       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.